CD8A and infection: ESAT-6 targeting to DEC205+ APCs prior to infection importantly reduces the onset time for specific-CD4+ and CD8+ T cell responses, correlating with cellular infiltrate, in vivo CTL killing assays and, ultimately, with reduced bacterial load in the lungs.